BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6507537)

  • 1. Midtrimester amniocentesis: obstetric outcome and neonatal neurobehavioral status.
    Finegan JK; Quarrington BJ; Hughes HE; Rudd NL; Stevens LJ; Weksberg R; Doran TA
    Am J Obstet Gynecol; 1984 Dec; 150(8):989-97. PubMed ID: 6507537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised trial of progesterone prophylaxis after midtrimester amniocentesis.
    Corrado F; Dugo C; Cannata ML; Di Bartolo M; Scilipoti A; Carlo Stella N
    Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):196-8. PubMed ID: 11750964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midtrimester genetic amniocentesis. A review of the fetal risks.
    O'Brien WF
    J Reprod Med; 1984 Jan; 29(1):59-63. PubMed ID: 6708022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal lung function following mid-trimester amniocentesis.
    Hunter AG
    Prenat Diagn; 1987 Jul; 7(6):433-41. PubMed ID: 3658917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss.
    Crane JP; Kopta MM
    Am J Obstet Gynecol; 1984 Dec; 150(7):813-6. PubMed ID: 6391172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy loss rates after midtrimester amniocentesis.
    Eddleman KA; Malone FD; Sullivan L; Dukes K; Berkowitz RL; Kharbutli Y; Porter TF; Luthy DA; Comstock CH; Saade GR; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Obstet Gynecol; 2006 Nov; 108(5):1067-72. PubMed ID: 17077226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis.
    Br J Obstet Gynaecol; 1978; 85 Suppl 2():1-41. PubMed ID: 104726
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group.
    Lancet; 1998 Jan; 351(9098):242-7. PubMed ID: 9457093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hazards of amniocentesis.
    Br Med J; 1978 Dec; 2(6153):1661-2. PubMed ID: 737430
    [No Abstract]   [Full Text] [Related]  

  • 10. Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy.
    JAMA; 1976 Sep; 236(13):1471-6. PubMed ID: 989112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ultrasonography on midtrimester genetic amniocentesis complications.
    Nolan GH; Schmickel RD; Chantaratherakitti P; Knickerbocker C; Hamman J; Louwsma G
    Am J Obstet Gynecol; 1981 Jul; 140(5):531-4. PubMed ID: 7246688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping.
    Cederholm M; Haglund B; Axelsson O
    BJOG; 2005 Apr; 112(4):394-402. PubMed ID: 15777434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic fluid alpha-fetoprotein levels and pregnancy outcome.
    Brumfield CG; Cloud GA; Finley SC; Cosper P; Davis RO; Huddleston JF
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):822-5. PubMed ID: 2445206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constriction of the umbilical cord as a cause of fetal demise following midtrimester amniocentesis.
    Robertson RD; Rubinstein LM; Wolfson WL; Lebherz TB; Blanchard JB; Crandall BF
    J Reprod Med; 1981 Jun; 26(6):325-7. PubMed ID: 7252953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early amniocentesis study: a randomized clinical trial of early amniocentesis and midtrimester amniocentesis. II. Evaluation of procedure details and neonatal congenital anomalies.
    Wilson RD; Johnson J; Windrim R; Dansereau J; Singer J; Winsor EJ; Kalousek D
    Fetal Diagn Ther; 1997; 12(2):97-101. PubMed ID: 9218950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midtrimester amniocentesis. An analysis of 923 cases with neonatal follow-up.
    Cruikshank DP; Varner MW; Cruikshank JE; Grant SS; Donnelly E
    Am J Obstet Gynecol; 1983 May; 146(2):204-11. PubMed ID: 6189400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal loss after amniocentesis in a series of 5,780 procedures.
    Gaudry P; Grangé G; Lebbar A; Choiset A; Girard S; Goffinet F; Lewin F
    Fetal Diagn Ther; 2008; 23(3):217-21. PubMed ID: 18417981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal exsanguination and other vascular injuries from midtrimester genetic amniocentesis.
    Young PE; Matson MR; Jones OW
    Am J Obstet Gynecol; 1977 Sep; 129(1):21-4. PubMed ID: 561540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 2136 genetic amniocenteses: experience of a single physician.
    Hanson FW; Tennant FR; Zorn EM; Samuels S
    Am J Obstet Gynecol; 1985 Jun; 152(4):436-43. PubMed ID: 4014336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.